Recent neuroimaging and postmortem studies have reported abnormalities in white matter of schizophrenic brains, suggesting the involvement of oligodendrocytes in the etiopathology of schizophrenia. This view is being supported by gene microarray studies showing the downregulation of genes related to oligodendrocyte function and myelination in schizophrenic brain compared to control subjects. However, there is currently little information available on the response of oligodendrocytes to antipsychotic drugs (APDs), which could be invaluable for corroborating the oligodendrocyte hypothesis. In this study we found: (1) quetiapine (QUE, an atypical APD) treatment in conjunction with addition of growth factors increased the proliferation of neural progenitors isolated from the cerebral cortex of embryonic rats; (2) QUE directed the differentiation of neural progenitors to oligodendrocyte lineage through extracellular signal-related kinases; (3) addition of QUE increased the synthesis of myelin basic protein and facilitated myelination in rat embryonic cortical aggregate cultures; (4) chronic administration of QUE to C57BL/6 mice prevented cortical demyelination and concomitant spatial working memory impairment induced by cuprizone, a neurotoxin. These findings suggest a new neural mechanism of antipsychotic action of QUE, and help to establish a role for oligodendrocytes in the etiopathology and treatment of schizophrenia.
Introduction
Schizophrenia is a complex and severe brain disorder characterized by disturbances of perception, emotion, social functioning and cognition. Although its clinical manifestations have been recognized for centuries and the treatment of this disorder has improved in recent decades, the etiology and fundamental pathophysiology of schizophrenia remain uncertain.
There are currently many hypotheses about the causal factors of schizophrenia, and most of them are encompassed in the neurodevelopmental theory of the illness. According to this theory, the interaction of genetic vulnerability and early environmental exposures can induce a developmental trajectory which culminates later in the clinical syndrome. [1] [2] [3] [4] Although this broad neurodevelopmental model has been the focus of schizophrenia research for decades; recent neural imaging studies have shown that schizophrenic patients have lower white matter volumes compared to matched normal controls. [5] [6] [7] [8] [9] Structural imaging studies using diffusion tensor imaging have demonstrated reduced anisotropy in several brain areas of schizophrenic patients, [10] [11] [12] [13] [14] suggesting that pathological process may take place in white matter fiber tracts. Moreover, a number of white matter disorders are associated with schizophrenia-like psychosis at a rate greater than chance. 15 Given that oligodendrocytes (Oligs) are myelinforming cells in the brain, it is unlikely that Oligs are spared in schizophrenia. In fact, as early as 1938, swollen Oligs were observed in schizophrenia brains postmortem. 16 However, Oligs have not been a focus of investigation in the brains of schizophrenic patients. Recent gene microarray studies have reported the downregulation of genes related to Olig function and myelination in schizophrenic brain compared to control subjects. [17] [18] [19] [20] [21] These genes include CNP (2 0 ,3 0 -cyclic nucleotide 3 0 -phosphodiesterase), myelin-associated glycoprotein, transferring, proteolipid protein 1, myelin basic protein (MBP) and quaking gene. Dysregulation of several of these genes has been shown to alter Olig development and function. 22, 23 If altered Olig function is an etiological factor or involved in the pathogenesis of schizophrenia, this kind of glial cells may respond to antipsychotic drugs (APDs) under both in vitro and in vivo conditions. The possibility to demonstrate this speculation is enhanced by the specific development characteristics of Olig cells suggested by recent magnetic resonance imaging studies. It was demonstrated that the frontal and temporal-lobe white matter volumes of normal males continue to increase into the mid-to late 40s, reaching maximum volume at age 47 in humans, 5 and the white matter myelination of these same regions also continues into the mid to late 40s. 24, 25 The myelination-driven white matter volume expansion of frontal and temporal-lobe regions is crucial for normal adult brain function. If normal white matter myelination/maturation is disrupted even in adulthood, normal adult brain function may become impaired. 5, 26 Schizophrenic patients treated with typical APDs had significantly larger right lateral and fourth ventricles compared to those on atypical APDs. 27 In spite of these current advances in human studies, there is little information available in cell culture and animal studies which are very necessary to demonstrate a putative role of Oligs in the pathogenesis and treatment of schizophrenia. There is only one study that directly investigated the expression of myelin/Olig-related genes in response to antipsychotic treatment. In this study, haloperidol (HAL) caused a decrease in the expression of the myelin/Olig-related genes in several white matter regions of the mouse central nervous system (CNS), whereas clozapine (CLO) had no effect on the expression of a subset of these genes. 28 In the present study, we investigated the regulatory capacity of APDs on the proliferation and differentiation of neural progenitor cells (NPCs). In addition, we observed the effect of quetiapine (QUE) on the myelination of axons in neocortical aggregate cell cultures. In adult C57BL/6 mice, we examined the effects of QUE on the cortical myelin breakdown and the changes in the animals' spatial working memory and locomotor activity induced by the neurotoxin cuprizone. This chemical agent is a copper chelator, which was shown to produce CNS myelin breakdown without damage to other cell types in CNS other than Oligs. Removal of cuprizone from the diet permits the study of remyelination. 29 
Materials and methods
Neural progenitor cell isolation and culture Neural progenitor cells were isolated from the cortex of E16-17 Sprague-Dawley (S-D) rat fetuses and cultured as described previously. 30 Cells were propagated in T-25 Falcon flasks (TPP, Switzerland) with the Dulbecco's modified Eagle's medium (DMEM)/ F12 medium supplemented with B27, 20 ng/ml fibroblast growth factor-2 (FGF-2; Chemicon, Temecula, CA) and 20 ng/ml epidermal growth factor (EGF; Chemicon). The first subcultures were designated as passage one. All experiments were carried out using the second to fourth passages of NPCs.
For the proliferation assay, 100 ml of single-cell suspension was plated into each well of noncoated 96-well plates with 1.5 Â 10 4 cells/well. After 12 h incubation, the cultures were treated with various concentrations (0.01, 0.1, 1, 10 or 100 mM) of QUE (AstraZeneca, Wilmington, DE, USA; dissolved in distilled water), olanzapine (OLA, Lilly Research Lab, Indianapolis, IN, USA; dissolved in distilled water), or HAL (Sigma-Aldrich, St Louis, MO, USA; dissolved in 1% dimethyl sulfoxide) for the times indicated. Cell proliferation was measured using a WST-8 assay cell counting Kit-8 (Dojindo Molecular Technologies, Gaithersburg, MD, USA) or a cell proliferation ELISA BrdU kit (Roche, QC, Canada). For the differentiation assay, the neurospheres were dissociated and cultured as monolayers on poly-Dlysine (100 mg/ml, Sigma-Aldrich)-coated glass coverslips or in poly-D-lysine-coated culture dishes. The cells were cultured in medium supplemented with 20 ng/ml FGF-2 and 20 ng/ml EGF for 24 h. The cell differentiation was induced by growth factor withdrawal and the cultures were treated with various concentrations (0.1, 0.3 or 1 mM) of QUE, CLO (Novartis Pharmaceuticals, Mississauga, ON, Canada), OLA or HAL. In some cultures, 2.5 mM of U0126 (Cell Signaling Technology, Beverly, MA, USA) was added 1 h before the addition of QUE. Cells were cultured for a further 6 days with a complete change of fresh medium and drugs once every 3 days. Differentiated cells were fixed for immunocytochemistry (ICC) or harvested for western blot analysis at day 3 and day 6.
Neocortical aggregate cell cultures
Neocortex rotation-mediated aggregate cell cultures were established as described previously, 31, 32 with some modification. Cerebral hemispheres of E16-17 S-D rat fetuses were dissociated with Accutase detachment medium (10 min at 371C) and then filtered through a 100 mm Nitex mesh to form a suspension of single cells in DMEM/F12 medium. Viable cells (1.5 Â 10 7 ) in 6 ml DMEM/F12 culture medium supplemented with 2% of B27, 50 ng/ml nerve growth factor (Chemicon), 50 mg/ml vitamin C 
WST-8 assay
The number of viable cells was estimated using the WST-8 assay, which provides effective and reproducible determination of the proliferation activity of NPCs. The WST-8 assay is based on the conversion of the tetrazolium salt WST-8 to highly water-soluble formazan by viable cells. The amount of formazan dye generated by the activity of the mitochondrial enzyme in cells is known to be directly proportional to the number of living cells. The proliferation activity of NPCs in 96-well microplates was measured by adding 10 ml of the cell counting Kit-8 solution into each well, followed by incubation of the microplates at 371C for 5 h. Absorbance was measured at 450 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA) with a reference wavelength of 650 nm.
BrdU incorporation analysis
The cells were incubated with 10 mM of 5-bromo-2-deoxyuridine (BrdU) at 371C for 4 h. After centrifugation at 300 g for 10 min, the labeling medium was removed by aspiration and the cellular DNA was denatured by the addition of 200 ml FixDenat solution for 30 min at 221C. The cells were incubated with anti-BrdU antibody conjugated with peroxidase for 120 min at 221C. After triple washing, 100 ml of peroxidase substrate solution was added to each well and the plates were incubated for 30 min at 221C. The number of neurons, Oligs, astrocytes and total cell numbers were determined using a Â 20 objective lens on an Olympus BX-51 fluorescence microscope. Cell counting was conducted on 10 randomly chosen fields for each coverslip by using the densitometer Image-Pro Plus image analysis system (Media Cybernetics, Silver Spring, MD, USA). Results are expressed as the mean7s.e.m. of data obtained from three separate experiments.
ICC for aggregate cell cultures. Aggregates were fixed with 4% PFA for 2 h at 41C. After triple rinsing in PBS and blocking with PBS containing 2% bovine serum albumin/0.3% Triton X-100 for 1 h at 221C, the aggregates were incubated in a cocktail solution containing the primary antibodies goat anti-MBP polyclonal antibody (1:300) and mouse antineurofilament 200 kDa monoclonal antibody (1:100) (Santa Cruz Biotech Inc.) at 41C for 24 h. Following triple rinses with PBS, the aggregates were incubated in another cocktail solution containing Alexa Fluor 488-conjugated anti-mouse IgG (1:600) and rhodamine-conjugated anti-goat IgG (1:600) at 41C overnight. After triple rinsing with PBS, the aggregates were mounted with anti-fade medium (Dako Cytomation, Carpinteria, CA, USA) between two coverslips and photographed using an Olympus FV5-PSU confocal laser microscope (Olympus, Japan). Analysis of the fluorescent images was carried out using Adobe Photoshop. Values were normalized to the percentage of immunofluorescence to total background. Representative fields photographed at Â 400 magnification (4-5 per aggregate) were randomly selected from six aggregates from each of two experiments.
ICC for brain sections. C57BL/6 mice were deeply anesthetized with pentobarbital (50 mg/kg i.p.) and perfused transcardially with 60 ml of 0.01 M PBS (pH 7.4). Their brains were removed and fixed in 4% PFA in PBS overnight at 41C. The brain samples were then cryoprotected in 30% sucrose at 41C. Serial coronal sections (30 mm) of the brains were cut using a sliding microtome (Laica Microsystems, Wetzlar, Germany) and collected in 6-well plates containing 0.01 M PBS. For immunoperoxidase staining of MBP, free-floating sections were pretreated with 0.6% hydrogen peroxide in methanol for 15 min, washed with PBS and incubated for 1 h at 221C with a blocking solution composed of 0.3% Triton X-100 and 5% normal rabbit serum in PBS. Sections were then incubated with goat antibody to MBP (Santa Cruz Biotech Inc.; 1/250) in the blocking solution overnight at 41C. After rinsing in PBS, the sections were incubated in biotinylated rabbit secondary anti-sera (1:200) of a Vectastain (Elite) ABC kit (Burlingame, CA) for 2 h at 221C. Following PBS rinses, the sections were incubated in avidin-biotin-horseradish peroxidase for 0.5 h at 221C. Finally, the sections were developed with a solution of 0.03% diaminobenzydine and 0.03% hydrogen peroxide in Tris/Hcl-buffered saline (0.05 M, pH 7.6). The immunohistochemical controls were performed as above except for the omission of the primary antibodies. No positive immunostaining was found in any of the controls. MBP immunoreactivity in the brain sections was measured using computerized image analysis system ImagePro Plus software (version 4.1, Fryer, Huntley, IL, USA). The results were expressed as the percentage of MBP-positive components over the total area of interesting.
Western blot analysis
Proteins were extracted from differentiated NPCs as well as aggregates at indicated treatment and time points using a Tris-ethylenediaminetetraacetic acid (EDTA) lysis buffer (1% Triton X-100, 10% glycerol, 20 mM Tris, pH 7.5, 1 mM EDTA) with freshly added Protease Inhibitor Cocktail (Sigma-Aldrich). After protein determination using a BCA kit, sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blotting were carried out. The following antibodies were used at the indicated dilutions: mouse anti-nestin (1:10 000), mouse anti-TuJ1 (b-tubulin; 1:1000), mouse anti-GFAP (1:10 000), mouse anti-CNPase (1:2000), goat anti-MBP polyclonal antibody (1:600), rabbit anti-Phospho-Akt (Ser473; 1:1000), rabbit-Akt (1:1000), rabbit anti-Phospho-Erk1/2 (extracellular signal-related kinase 1 2 1:1000) and rabbit anti-Erk1/2 (1:1000; Cell Signaling Technology). Antibody against b-actin (1:1000; Sigma-Aldrich) was used as an internal control for the concentration of protein loaded. Immunoreactive proteins were detected using HRP-conjugated horse anti-mouse (1:2000; Amersham Biosciences, Buckinghamshire, UK) or donkey anti-rabbit antibody 1:2000 (Cell Signaling Technology) and visualized by using an ECL detection kit (Amersham Biosciences). Quantification of the immunoblots was carried out by densitometric analysis of chemiluminescenceexposed films, using Image-Pro Plus software (version 4.1) and the results expressed as arbitrary densitometric units.
Electron microscopy
Electron microscopy was used to observe the elaboration of the myelin sheaths in neural cell aggregate cultures as described previously. 31 Briefly, 10-15 aggregates from control and QUE-treated (0.5 mM) cultures were fixed at DIV 24, 36 and 46 with 0.9% formaldehyde/2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2). Overnight fixation at 41C was followed by postfixation in Osmium Black (1% osmium tetroxide (OsO 4 , 1.875% potassium ferrocyanide in 0.08 M cacodylate buffer). The aggregates were rinsed twice (5 min) in 0.08 M cacodylate buffer and then dehydrated in ascending concentrations of ethanol. Aggregates were subsequently embedded in Epon/Araldite, sectioned at 1 mm and stained with Toluidine blue to demonstrate the presence of myelin and different cell types. Thin sections (400 nm) were stained with ethanolic uranyl acetate and lead citrate, and photographed with a Philips 310 transmission electron microscopy.
Animals and drug administration
Timed pregnant S-D rats and 8-week-old C57BL/6 mice used in the study were purchased from Charles River (St. Constant, QC, Canada). The former was used to provide rat embryos from the brain of which NPCs were isolated as described before. The latter was used to test effects of QUE on Olig alterations and the ensuing behavioral changes. All of the procedures involving animals were in accordance with the guidelines established by the Canadian Council on Animal Care and approved by the University of Saskatchewan Animal Care Committee.
The C57BL/6 mice were randomly assigned to the following four groups: control, cuprizone, QUE and QUE þ cuprizone. Each group had six mice. The mice in the control and QUE groups were fed normal mouse chow for 5 weeks, while those in the cuprizone and QUE þ cuprizone groups were fed normal mouse chow for 1 week and then mouse chow containing 0.2% cuprizone (W/W) for additional 4 weeks. QUE, dissolved in distilled water (10 mg/kg/day), was given to the mice in the QUE and QUE þ cuprizone groups for 5 weeks, while those in the control and cuprizone groups were given only distilled water. The Y-maze task was carried out on the last day of the 5-week period.
Y-maze task
The experimental apparatus consisted of a Y-maze made of three arms. Each arm of the Y-maze was 35 cm long, 25 cm high and 10 cm wide and positioned at an equal angle (labeled A, B and C). The apparatus was placed 40 cm above the floor and was surrounded by various extra-maze cues. Each mouse was placed at the end of one arm and allowed to move freely through the maze during an 8 min session. The sequence of arm entries was recorded manually (that is, ABCBAC,and so on). An actual alternation was defined as entries into all three arms on consecutive occasions. Therefore, the maximum alternation was the total number of arm entries minus two, and the percentage of alternation was calculated as (actual alternations/maximum alternations) Â 100. The total number of arms entered during the sessions was also determined.
Statistical analysis
Data are expressed as mean7s.e.m. One-way or twoway analysis of variance (ANOVA) was used to test statistical significance among three or more experimental groups, followed by Dunnett's post-hoc or Tukey's post-hoc test. Comparisons between two experimental groups were made by the Student's t-test. A probability of P < 0.05 was considered statistically significant. 30 were used to study effects of HAL and QUE on NPCs. In such cultures, floating cells proliferated and assembled into round clusters, the neurospheres, over a time period of 3-5 days, and about 90% of cells in the neurospheres were positive for nestin (a neural stem cell protein). Incubation of the cultures in growth factor (FGF-2 and EGF)-free medium for 6 days caused changes in the cell composition of the neurospheres, as indicated by the presence of Tuj1-, GFAP-and CNP-positive cells, in addition to the nestin-positive cells. The differentiation of NPCs was confirmed by western blot analysis, in which the expression of nestin decreased, and the expression of Tuj1, GFAP as well as CNP increased with time (Supplementary Figure 1) . The NPCs were also able to proliferate (described later).
Results

Neural
Quetiapine increases neural progenitor cell proliferation in a growth factor-dependent manner To examine potential effects of APDs on NPC proliferation, we treated neurosphere cultures with QUE, OLA or HAL at various concentrations for 48 h, in the presence of the growth factors EGF and FGF-2, and then measured the number of viable cells by using WST-8 assay and BrdU incorporation analysis. The results of WST-8 assay (Figure 1a) showed that all the three drugs affected the viable cell number of neurospheres in a dose-dependent manner. Specifically, at the concentrations of 0.1 and 1 mM; both QUE and OLA increased the viable cell number of neurospheres when compared to controls, whereas at other concentrations they had no effect or decreased the viable cell number. HAL had no effect or decreased the viable cell number. Based on these data, the effects of QUE and OLA were further tested by using BrdU incorporation analysis, which showed that only 1 mM QUE increased the number of BrdU-labeled cells in the neurospheres while other treatments had no effect or decreased the number of BrdU-labeled cells in the neurospheres (Figure 1b) .
The above results suggest two possibilities: either QUE is a mitogen for NPCs or it only enhances the mitogenic effect of growth factors (FGF-2 and EGF) in the medium. To determine which is the case, we supplemented the medium with EGF (20 ng/ml), FGF-2 (20 ng/ml) or EGF þ FGF-2, then compared the results from these different treatments (including the cultures treated with QUE only). The WST-8 assay showed (Figure 1c ) that (1) QUE had no effect on the number of viable cells in the neurosphere cultures in the absence of the growth factors; (2) both EGF and FGF-2 increased the number of viable cells in the neurosphere cultures; (3) only the combination of QUE þ EGF þ FGF-2 significantly increased the number of viable cells in the neurospheres as compared to the cultures treated with EGF þ FGF-2, while no significant differences were found when comparisons were made between QUE þ EGF and EGF treatments, and between QUE þ FGF-2 and FGF-2 treatments. These data indicate that QUE enhances the mitogenic activity of EGF and FGF-2, but not either one of EGF or FGF-2, while QUE per se has no mitogenic effect on NPCs.
Quetiapine stimulates oligodendrocytic differentiation via phosphorylation of ERK1/2
To determine whether APDs affect the differentiation of NPCs, we disaggregated neurospheres and grew the cells in monolayer cultures. The cells grew for 6 days in a growth factor-free medium to which various concentrations of CLO, OLA, QUE or HAL were added. The cells were then stained using Hoechst cell nuclear dye 33258 following ICC tests with the antibody to CNP. Among the atypical APDs, only QUE-treated cultures showed many more CNP-positive cells as compared to control cultures (Figure 2a) . The results of western blot analysis carried out in the parallel experiments also showed increases in levels of CNP and MBP in QUE-treated cultures (Figure 2b) . Neither did HAL show stimulation on the number of CNP-positive cells and expression levels of CNP and MBP in NPCs (data not shown).
Further, we explored possible signal pathways involved in the regulation of oligodendrocytic differentiation by QUE. We examined the pathways of ERK1/2 and phosphatidylinositol-3 kinase (PI-3K) in the cultured cells. We found that (1) QUE (1 mM) increased phosphorylated levels of ERK1/2, but did not change the total ERK1/2. In the same experiments, QUE had no effect on the phosphorylation of Akt, a PI-3K-dependent kinase (Supplementary Figure 2) ; (2) the compound U0126 (a potent specific inhibitor of MEK), 33 at a concentration of 2.5 mM, blocked the increase in ERK1/2 phosphorylation induced by QUE ( Figure 3a) ; (3) U0126 abolished the increase in CNP levels (Figure 3b) as well as the increase in the number of CNP-positive cells induced by QUE (Figure 3c ). Together, these data indicate that QUE stimulates the differentiation of NPCs into the Olig lineage by stimulating the phosphorylation of ERK1/2.
To determine if QUE has any effect on the differentiation of NPCs into cell lineages other than the Olig lineage, the QUE-treated (1 mM for 6 days) and control cultures were examined immunocytochemically using antibodies to CNP, GFAP, Tuj1 or MBP, and stained with Hoechst 33258. Representative images are displayed in Supplementary Figure 3 and quantitative data are shown in Supplementary  Table 1 . In QUE-treated cultures, there were significant increases in the number of CNP-and MBPpositive cells, and a decrease in the number of GFAP-positive cells as compared to the drug-free controls. However, the treatment did not affect the number of Tuj1-positive cells and other unidentified cells. These results were confirmed by western blot analysis that showed the QUE-induced changes in levels of CNP, GFAP, Tuj1 and MBP proteins in the cultures (Supplementary Figure 4) .
Quetiapine facilitates myelination in rat embryonic neocortical aggregate cell cultures
To investigate whether QUE could induce Olig to myelinate axons, we used rat embryonic (E16-17) neocortical aggregate cultures, in which the myelination process is similar to that in the developing brain. 31, 32 The cultures were treated with various concentrations (0, 0.25, 0.5 or 1 mM) of QUE for 6 days and then the extract of cells was subjected to western blot analysis. The results (Figure 4) showed that QUE dramatically increased MBP expression levels in the cells in a dose-dependent manner (F (1, 16) = 102.53, P < 0.0001). Based on these results, 0.5 mM of QUE was selected for further experiments in which cells were cultured for various periods (12, 24 and 36 days). It was found that MBP levels, determined by western blot, increased as the culture period lengthened, and QUE-treated cells showed higher MBP levels as compared to controls (Supplementary Figure 5) . In cultures that were treated with 1 mM of QUE for 6 days, cells were examined by immunofluorescence. The immunofluorescent images ( Figure 5) showed that MBP-positive components were more frequently observed in QUE-treated cultures as compared to control cultures, although there was a comparable amount of neurofilament-200 (NF-200)-positive fibers. This phenomenon was confirmed by confocal microscopy method in which double-labeled immunofluorescent images were obtained. The quantitative data of the immunofluorescent staining showed that QUE markedly increased MBP-positive components in the cultures as compared to controls ( Figure 5 ). The myelination was observed in longest cultures (for 46 days), by an electron microscopy. The myelinated axons were found only in QUE-treated cultures (Supplementary Figure 6) .
Quetiapine prevents cortical myelin breakdown and behavioral changes of C57BL/6 mice chronically administered with cuprizone To test possible in vivo effects of QUE under the pathological condition of myelin breakdown, we fed 8-week-old C57BL/6 mice with 0.2% cuprizone (a toxin causing myelin breakdown) in the diet for 4 weeks. The treatment did cause myelin breakdown in the whole brain, especially in cortex, as indicated by immunohistochemical staining using the antibody to MBP (Figure 6 ). This myelin breakdown is an early observed event, with damage only to Oligs in CNS. 34 However, in the mice that received QUE (10 mg/kg/ day in the water) for 5 weeks (started 1 week before cuprizone treatment) in conjunction with 0.2% cuprizone treatment for 4 weeks, the extent of myelin breakdown in the brain was much less. In contrast, chronic administration of QUE in the absence of cuprizone did not produce any change compared to the control animals. Two-way ANOVA analysis showed significant effects of cuprizone (F (1, 16) = 103.85, P < 0.0001) and QUE (F (1,16) = 11.09, P = 0.004), although there was no interaction between the two factors (F (1,19) = 2.5, P = 0.13).
In the same animals, cuprizone caused marked behavioral changes indicated by the results of Y-maze task, which showed an increase in the number of arm entries and a decrease in alternation behavior. These cuprizone-induced changes were effectively prevented by chronic administration of QUE (Figure 7) . 
Discussion
For the first time, the present study demonstrated that QUE, but not other APDs, increases the differentiation of multipotent NPCs into Oligs (Figure 2 ), whereas it decreases astrocytic differentiation and has no effect on neuronal differentiation (Supplementary Figure 3 and Supplementary Table 1) . These results are similar to the recent observation on OLA that increased the size of GFAP-labeled astrocytes but had no detectable effects on neurosphere differentiation. 35 More interestingly, the stimulation of QUE on the differentiation of NPCs is similar to that exerted by insulin-like growth factor I (IGF-I), which is a potent inducer of Olig development and myelination. IGF-I was reported to stimulate the differentiation of multipotent adult rat hippocampus-derived NPCs into Oligs. The IGF-I-induced oligodendrocytic differentiation occurred in a dose-dependent manner, whereas the percentage of Tuj1-positive cells did not change at any of the tested concentrations. 36 However, intracellular mechanisms for QUE-and IGF-I-induced oligodendrocytic differentiation appear to not be the same. In the present study ERK1/2, but not PI-3K, pathway was required for QUE-induced differentiation of NPCs into Oligs (Figure 3 and Supplementary Figure  2) , whereas both signaling pathways were required for the full effect of IGF-I on Olig development in primary mixed rat cerebrocortical cell cultures. 37 Oligs produce myelin membranes that wrap around axons and are interspersed by unmyelinated nodes that permit salutatory conduction of nerve impulses. These cells progress through several stages starting from the expression of particular Olig-associated genes such as CNP. 38 As Oligs mature, they express MBP. In the present study, QUE not only instructed NPCs to become CNPase-positive Oligs (Figure 2 ), but also facilitated the maturation of newly formed Oligs, as indicated by the increase in MBP expression ( Figure 4 ) and myelination observed in QUE-treated aggregate cultures ( Figure 5 and Supplementary  Figures 4 and 5) , which provide a system that incorporates a mixed cell population that reliably models in vivo myelinogenesis in developing CNS. 39 In contrast, CLO and OLA did not show any stimulation on the expression of CNP and MBP of NPCs (Figure 2) . Currently, we do not know how to explain the differences among the atypical APDs. There are a few studies reporting that APDs, including chlorpromazine, HAL, CLO, OLA and ziprasidone, upregulated several genes involved in cholesterol and fatty acid biosynthesis in cultured human glioma cells. The drugs also activated the sterol regulatory element-binding protein transcription factors which control the expression of those cholesterol and fatty acid biosynthesis-related genes. 40, 41 Unfortunately, QUE was not included in the above studies. Therefore, we do not know if the mechanism suggested by the studies can apply for QUE. But, we did show that QUE was different from other APDs in their effects on the differentiation of NPCs and on the maturation of newly formed Oligs. In line with our results, Narayan et al. 28 showed that other APDs, rather than QUE, had no effect or caused a decrease in the expression of eight genes known to play critical roles in myelin/Olig function.
The C57BL/6 mice fed with cuprizone not only showed myelin breakdown in the white matter ( Figure 6 ) but were also abnormal in their behaviors indicated by a significant increase in the total number of arm entries (locomotor activity) and a decrease in spontaneous alternation in the Y-maze tests (Figure 7) . These results suggest an association between the cuprizone-induced myelin breakdown and spatial working memory impairment and hyperlocomotion. Spatial working memory impairment has been regarded as an endophenotypic marker for schizophrenia, 42 and hyperactivity has been observed in various pharmacological animal models of schizophrenia, 43 therefore we used Y-maze test for the animals investigated in the present study. In fact, the antagonism of hyperlocomotion induced by dopamine receptor agonist has been used traditionally to predict antipsychotic efficacy of novel agents. 44, 45 Taken together, our data suggest that the cuprizonefed mice may be used as a useful animal model of schizophrenia.
One of the most important findings in the present study is that chronic administration of QUE prevented C57BL/6 mice from cuprizone-induced myelin breakdown in the brain and the ensuing behavioral changes in the animals, whereas the drug had no effect on normal animals (Figures 6 and 7) . The results indicate that QUE acts on broken white matter, an important pathological component in the pathophysiology of schizophrenia. 5 This novel finding advanced our current knowledge revealed by multiple lines of evidence implicating abnormal Oligs and myelin in schizophrenia. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Also, it is consistent with the clinical observation that QUE has direct effects on negative symptoms and cognitive deficits of patients with schizophrenia. 46, 47 Indeed, the alterations in white matter have been considered to be associated with the negative symptoms of schizophrenia. 48 Olanzapine increased the number of viable cells in the neurospheres but did not increase the number of BrdU-labeled cells. QUE increased both viable cell numbers in WST-8 assay and stimulated cell proliferation indicated by increases in the number of BrdUlabeled cells (Figure 1 ). These data suggest that QUE and OLA exerted differential effects on the survival and proliferation of cells in neurosphere cultures. NPCs in the neurospheres have characteristics of neural stem cells (Supplementary Figure 1) , that is, self-renewal and the ability to differentiate into neurons, astrocytes and Oligs. In adult individuals, NPCs can replace neural cells lost from normal turnover or due to damage. 49 The stimulation of NPC proliferation by QUE depends on the presence of EGF and FGF-2 in the medium (Figure 1c ), suggesting that QUE by itself has no direct mitogenic effect on NPCs, but can enhance mitogenic effects of the growth factors. Both EGF and FGF-2 are neurotrophic factors which have been implicated in a variety of neurodevelopmental processes.
50, 51 Patients with schizophrenia showed abnormal expression of EGF and its receptor in their forebrain and serum, and decreased neural stem cell proliferation. 52 Furthermore, QUE and other atypical APDs have been shown to regulate/ modulate the expression of FGF-2 in the brain. 53, 54 Together, these data suggest that QUE may target neural stem cells via regulating the expression of EGF and FGF-2 in the brain.
In summary, (1) QUE increased proliferation of NPCs in the presence of growth factors; (2) QUE directed the differentiation of NPCs into Olig lineage through extracellular signal-related kinases; (3) QUE increased the expression of MBP and stimulated the myelination of axons by Oligs in rat embryonic neocortical aggregate cultures; (4) chronic administration of QUE prevented the cuprizone-induced myelin breakdown and cognitive impairments in C57BL/6 mice. These data not only provide compelling evidence that QUE targets Oligs and thereby improving animals' behavioral changes ensuing Olig alterations, but also help to establish a role for Oligs in the etiopathology and treatment of schizophrenia. Furthermore, the important long-term implications of this study can be anticipated in the context of possible involvement of Oligs in multiple neuropsychiatric disorders that may share a common development problem of myelination, metachromatic leukodystrophy (MLD) and the chromosome 22q11-deletion syndrome (22qDS), for example. Patients with MLD experience a host of psychotic symptoms, including auditory hallucinations, thought fragmentation, catatonic posturing, bizarre gesturing, poor concentration, inappropriate effect and poor insight. 55 22qDS was often indistinguishable from schizophrenia until the recent discovery of its genetic basis. The subjects of 22qDS show reductions in white matter volume twice as large as their gray matter volume reductions. 56, 57 Last but not least, the results of this study imply that pro-myelinating interventions are likely potential approaches to treat patients with schizophrenia. If this envision is demonstrated in the future, the face of modern neuropsychopharmacology will be changed. 
